A method based on the release of tritiated water from [9,1O(n)-3H] palmitic and myristic acids previously described for fibroblasts, was adapted for lymphocytes for the rapid diagnosis of fatty acid oxidation disorders. Optimal concentrations for both substrates and linearity of the assay were established. Normal values were established in control subjects of different age groups (58 children and 117 adults) and 16 patients with known fatty acid oxidation disorders were tested. Tritiated water production from patients' lymphocytes was expressed as a ratio between residual oxidations of palmitate and myristate and the results show that this method allows good differentiation between long chain and medium chain fatty acid oxidation defects.
SUMMARY. A method based on the release of tritiated water from [9,1O(n)-3H] palmitic and myristic acids previously described for fibroblasts, was adapted for lymphocytes for the rapid diagnosis of fatty acid oxidation disorders. Optimal concentrations for both substrates and linearity of the assay were established. Normal values were established in control subjects of different age groups (58 children and 117 adults) and 16 patients with known fatty acid oxidation disorders were tested. Tritiated water production from patients' lymphocytes was expressed as a ratio between residual oxidations of palmitate and myristate and the results show that this method allows good differentiation between long chain and medium chain fatty acid oxidation defects.
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Inborn errors of mitochondrial [1-oxidation of fatty acids are being increasingly identified. I Beta-oxidation defects are often characterized by acute episodes of metabolic decompensation with hypoglycaemia and features resembling Reye's syndrome and prompt recognition of such individuals is particularly important. The diagnosis of these disorders, however, remains difficult and there are a number of pitfalls." Urine is generally the first material investigated, but abnormal urinary organic acid excretion is sometimes . intermittent and non-specific and in some disorders it is always absent. A variety of in vivo tests including fasting test, phenylpropionate test and long chain triglycerides loading test have been developed. They are difficult to perform in infants, and need close clinical supervision. Assay of fatty acid oxidation in cultured fibroblasts is currently the main method of diagnosis.' Assays based on oxidation of (1-14 C) octanoate and (l_14C) palmitate in mixed leukocytes have been suggested as an alternative method for rapid diagnosis.t-' We have investigated an assay based on formation of tritiated water from [9,10 (n)-3H] palmitic and [9,10(n)-3H] myristic acids in lymphocytes as an alternative.
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MATERIAL AND METHODS
Ficoll-Paque was from Pharmacia (Uppsala, Sweden). Twenty-four well microtitre plates were from Costar (Cambridge, USA). Amersham International (Buckinghamshire, UK) supplied [9,1O(n)-3H] palmitic acid and [9,1O(n)-3H] myristic acids. Palmitic and myristic acids were from Fluka (St Quentin, France). Fatty acid-free fraction V bovine serum albumin and Dowex-1 anion exchange resin were from Sigma Chemical Co. (St Louis, MA, USA). Pico-fluor 40 was from Packard instruments (Groningen, The Netherlands). All other reagents were of analytical grade.
SUBJECTS
Sixteen patients (3 adults and 13 children) were studied. Fatty acid oxidation in their lymphocytes was assessed either during the course of the initial diagnostic approach (patients I, 2, 4-8, 10, 11, 15, 16) or later in established cases, during annual metabolic check-up (patients 3, 9, [12] [13] [14] . Details of the diagnosis, and other features of these patients are given in Table 1 .
One hundred and seventy-five subjects, 117 adults and 58 children (age range: 10 days to 16 years) were studied as controls. Adults were volunteers, members of the laboratory staff or blood donors. Children in the control group were those first referred for screening of a fatty acid oxidation disorder but found to show no evidence of a fatty acid oxidation defect.'! In all subjects, 5-10 ml of fasting blood sample were taken into EDTA tubes.
METHODS
Mononuclear cells were isolated using a Ficoll-Paque gradient. 12 The cell pellet was washed twice with Dulbecco's phosphate buffered saline (PBS) and suspended in PBS supplemented with 0·9 mM Ca 2 + and 0·5 mM Mg 2 + , pH 7·35 (PBSs). The amount of proteins in the cell suspension was determined'! after solubilization 3H 2 0 was recovered by ion-exchange treatment on DOWEX-1 columns, as previously described, 14 with some modifications. The reaction mixture was removed after the incubation and added to a centrifuge tube containing 0·2 mL of cold 10070 (wt/vol) trichloroacetic acid. After 10 min of centrifugation at 2200 g at 4°C, aliquots of supernatants (350 JLL) were immediately removed, mixed with 55 JLL of 6N NaOH and applied to a 0'7 mL DOWEX-1 column in a Pasteur pipette. Columns were eluted with 1. 5 mL of distilled water and the eluate was collected in a scintillation vial containing 10mL of Picofluor 40.
Activities are expressed as nmol 3H 2 0 per mg protein per hour. With each run of patient samples, a sample from a control subject was included and all patient samples were assayed in triplicate. Patients' results were also calculated as a percentage of the control for each substrate. From these percentages the ratio of palmitate oxidation to myristate oxidation (P/M ratio) was calculated ( Table 2) .
RESULTS
To determine the optimum concentration of substrates, samples containing 60 JLg of cell protein were incubated with different concentration of substrate for 2 h. Maximal activities were obtained at concentrations~100 JLmol/L for the two substrates (Fig. 1) . This concentration was chosen for routine assays. Linearity studies showed that 3H 2 0 production was linear between 20 and 100 JLg of proteins and for up to 4 h of incubation (data not shown). All further determinations were therefore conducted with 30-70 JLg of cell protein per sample and for 2 h incubation period.
Storage of blood at 4°C resulted in a slow reduction in fatty acid oxidation by lymphocytes, with a loss of 30070 after 24 h. In view of these findings, lymphocytes were used within 6 h of blood collection. Storage of prepared lymphocytes in Ham FlO medium at 4°C for up to 24 h had no effect on oxidation of palmitate and myristate.
In routine assays both substrates were tested simultaneously, on the same lymphocyte sample. In control subjects tritiated water production from palmitic or myristic acid was not dependent on age (Table 2 ) and oxidation rate of myristate was higher than that of palmitate. In patients three different patterns of results were seen.
Group I. P /M ratio close to 1: Detritiation of both substrates was impaired to a similar degree in defects of long chain fatty acid (LCFA) transport into the mitochondria. P /M ratio close to one (0' 86-1 '18) was found in patients with PCD, CPTl deficiency, CPT2 deficiency and CATR deficiency. Supplementation of the incubation medium with 1 mM L-carnitine corrected the abnormalities in the oxidation of palmitate and myristate in PCD patients only ( Table 2) . Production of 3H 2 0 was higher in the adult form of CPT2 deficiency than in the infantile form. Oxidation of palmitate and myristate were very low in CPTl and CATR deficiency.
Oxidation of palmitate and myristate were also low in a patient with (MAD:M). The P/M ratio was 1 ,14. Differentiation of this disorder from a defect restricted to long chain fatty acids requires examination of the urinary organic acid profile.
Group II. Decreased P/M ratio: 3H-palmitate oxidation was impaired in lymphocytes from four patients with 3-hydroxy dicarboxylic aciduria. These patients had a multiple or a single defect of the mitochondrial trifunctional protein. Patients 10 and 11 had a combined defect of long chain enoylCoA hydratase (LCEH), long chain 3-hydroxy acylCoA dehydrogenase (LCHAD), and long chain 3-ketoacylCoA thiolase (LCKT). Patients 12 and 13 had an isolated LCHAD deficiency.
3H-myristate oxidation was variable in these four cases: results were either in the normal range (patient 10) or moderately decreased (patients [11] [12] [13] .
Group Ill. Increased P/M ratio: 3H-myristate oxidation was impaired to a greater extent than 3H-palmitate oxidation in lymphocytes from the three patients with MCAD deficiency giving P/M ratios >2'2. In obligate heterozygotes of CPTl, iCPT2 or MCAD deficiencies (father and mother of index cases) there was no evidence of impaired palmitate or myristate oxidation (data not shown).
DISCUSSION
Our work shows that assays based on the release of 3H 20 first described for fibroblasts, IS are also suitable for lymphocytes. Simultaneous measurement of 3Hp production from [9,IO(n)-3H] palmitate and [9,10 (n)-3H] myristate can detect impaired oxidation of fatty acids in homozygous patients and give indications on the chain length specificity of the metabolic block. The P1M ratio was calculated from percentages rather than absolute values as it has been shown's that there is significant interassay variation, mainly due to problems in achieving reproducibility in binding the substrates to bovine serum albumin.
Normal P/M ratio, in the absence of a specific organic acid profile indicative of multiple dehydrogenation defect, is in favour of a LCF A defect related to transport into the mitochondrion by the carnitine shuttle. Normalization of 3H 20 release from both substrates, by supplementation of the medium with 1 mM L-carnitine, allows differentiation of PCD from other defects: CPTl, CPT2 and CATR deficiencies.
Decreased P1M ratio is encountered in patients with a single or a multiple defect of MTP. A lower [9,IO(n)-3H] palmitate oxidation compared to [9,IO(n)-3H] myristate oxidation was previously reported in fibroblasts of patients with 3-hydroxydicarboxylic aciduria.P This probably reflects the greater activity of short chain hydroxy acylCoA dehydrogenase with Cl4 than with Cl6 substrates." The release of C02 from (1-14C) palmitate was shown to be normal or marginally low in fibroblasts from these patientsI5 and seems less discriminant than 3H 20 release assays to detect this type of defect.
Increased P/M ratio is observed when 3H_ myristate oxidation is impaired at a greater extent than 3H-palmitate oxidation. This pattern is observed in patients with MCAD deficiency where the metabolic block is located below octanoylCoA. This rapid and low-cost method allows the detection of defect in long or medium chain fatty acid oxidation within a few hours. It can be useful in two situations:
(A) Deficiency of long-chainfatty acid oxidation, like systemic CPT2, CATR, or MTP deficiency may present as a life threatening emergency in the neonate. In these patients, urinary organic acid A"" CIi" Biochem 1995: 32 profile may not be helpful;'! and the determination of plasma and urine acylcarnitine profile is the only other method to detect LCFA defects, but needs sophisticated instrumentation. This situation requires urgent dietary prevention and cannot await for functional investigation. (B) In non-critical situations, such as in patients after recovery from an acute episode of decompensation, and in siblings of such patients, this test can be used during the course of metabolic investigation of a suspected fatty acid oxidation defect. As described previously, 2 the complete protocol requires determinations of free and total carnitine levels in plasma and urine and determination of urinary organic acid profile, in basal conditions or under a provoked metabolic stress, such as long-chain triglycerides loading test, a phenylpropionate loading test, or a 24-h fasting test. Data obtained on lymphocytes help to avoid such in-vivo functional tests, which are difficult to perform in infants and need clinical supervision by a skilled medical team. Results from the test described here is also useful, before sending a skin biopsy to a highly specialized laboratory, for the definite enzymatic diagnosis.
It must be stressed, however, that this investigation always needs a high index of clinical suspicion in order to avoid unnecessary requests.
